Clinical trials data
Verbal Learning in mild cognitive impairment trials: 183 registered studies
Every registered mild cognitive impairment study on ClinicalTrials.gov that names Verbal Learning in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered mild cognitive impairment studies name it in an outcome measure
- 183
- Name it in a primary outcome, 55%
- 101 of 183
Tests named in the same studies
- 1
Trail Making Test84 studies, 36 as a primary outcome
- 2
Verbal Fluency69 studies, 25 as a primary outcome
- 3
Digit Span Test59 studies, 27 as a primary outcome
- 4
Picture Naming Test45 studies, 14 as a primary outcome
- 5
Category Fluency36 studies, 19 as a primary outcome
- 6
Stroop Color-Word Test35 studies, 9 as a primary outcome
- 7
Symbol Coding28 studies, 13 as a primary outcome
- 8
Short Story Recall22 studies, 13 as a primary outcome
- 9
Complex Figure Copy and Recall20 studies, 9 as a primary outcome
- 10
Clock Drawing Task15 studies, 7 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 2 |
| 2009 | 1 | 1 |
| 2010 | 4 | 4 |
| 2011 | 6 | 3 |
| 2012 | 8 | 4 |
| 2013 | 5 | 3 |
| 2014 | 2 | 1 |
| 2015 | 7 | 6 |
| 2016 | 11 | 7 |
| 2017 | 6 | 4 |
| 2018 | 11 | 9 |
| 2019 | 18 | 11 |
| 2020 | 10 | 4 |
| 2021 | 12 | 8 |
| 2022 | 11 | 3 |
| 2023 | 22 | 12 |
| 2024 | 18 | 8 |
| 2025 | 11 | 3 |
| 2026 | 16 | 7 |
Phases and study sizes
By phase
- Early phase 14 studies, 2 as a primary outcome
- Phase 12 studies, 2 as a primary outcome
- Phase 1/24 studies, 2 as a primary outcome
- Phase 216 studies, 10 as a primary outcome
- Phase 34 studies, 3 as a primary outcome
- Phase 44 studies, 3 as a primary outcome
- Not applicable124 studies, 70 as a primary outcome
- Observational25 studies, 9 as a primary outcome
Participants per study
- Phase 277 median, 43 to 148
- Not applicable60 median, 31 to 113
- Observational200 median, 100 to 600
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 15 | 77 | 43 to 148 |
| Not applicable | 123 | 60 | 31 to 113 |
| Observational | 25 | 200 | 100 to 600 |
When mild cognitive impairment trials measure it
Latest time point of each outcome
- Within a day12 outcomes, 6 as a primary outcome
- Up to 4 weeks15 outcomes, 10 as a primary outcome
- 1 to 3 months45 outcomes, 29 as a primary outcome
- 3 to 6 months38 outcomes, 26 as a primary outcome
- 6 to 12 months32 outcomes, 11 as a primary outcome
- 1 to 2 years14 outcomes, 8 as a primary outcome
- Over 2 years15 outcomes, 5 as a primary outcome
- No duration given12 outcomes, 6 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
171 of the 183 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting40 studies, 20 as a primary outcome
- Not yet recruiting11 studies, 3 as a primary outcome
- Active, not recruiting3 studies, 1 as a primary outcome
- Completed87 studies, 52 as a primary outcome
- Stopped early10 studies, 7 as a primary outcome
- Status unknown32 studies, 18 as a primary outcome
What they test
- Behavioral74 studies, 42 as a primary outcome
- Drug22 studies, 11 as a primary outcome
- Device46 studies, 29 as a primary outcome
- Dietary supplement11 studies, 6 as a primary outcome
- Procedure1 studies, 0 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Biological4 studies, 2 as a primary outcome
- Radiation2 studies, 1 as a primary outcome
- Combination product3 studies, 2 as a primary outcome
- Other43 studies, 25 as a primary outcome
- None given12 studies, 3 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States79 studies, 48 as a primary outcome
- Canada16 studies, 6 as a primary outcome
- China15 studies, 5 as a primary outcome
- Italy10 studies, 4 as a primary outcome
- Germany5 studies, 1 as a primary outcome
- Greece5 studies, 5 as a primary outcome
- Singapore5 studies, 3 as a primary outcome
- Spain5 studies, 3 as a primary outcome
- Switzerland5 studies, 2 as a primary outcome
- United Kingdom5 studies, 2 as a primary outcome
- Netherlands4 studies, 3 as a primary outcome
- South Korea4 studies, 2 as a primary outcome
26 countries in all. A study with sites in several counts in each; 17 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed mild cognitive impairment studies that name Verbal Learning: 46 of 87, 53%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed mild cognitive impairment studies that name Verbal Learning | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 16, 18% | 776, 10% |
| Results on ClinicalTrials.gov only | 19, 22% | 1,139, 14% |
| A results paper only | 11, 13% | 1,711, 22% |
| Neither | 41, 47% | 4,327, 54% |
The 183 studies
183 studies match. 101 name Verbal Learning in a primary outcome. Median size 69 participants. Median time to the primary outcome: 4 months.
Loading 183 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 2 |
| 2009 | 1 | 1 |
| 2010 | 4 | 4 |
| 2011 | 6 | 3 |
| 2012 | 8 | 4 |
| 2013 | 5 | 3 |
| 2014 | 2 | 1 |
| 2015 | 7 | 6 |
| 2016 | 11 | 7 |
| 2017 | 6 | 4 |
| 2018 | 11 | 9 |
| 2019 | 18 | 11 |
| 2020 | 10 | 4 |
| 2021 | 12 | 8 |
| 2022 | 11 | 3 |
| 2023 | 22 | 12 |
| 2024 | 18 | 8 |
| 2025 | 11 | 3 |
| 2026 | 16 | 7 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 14, other 169. Interventional 158, observational 25.
As a primary outcomeSecondary or other outcomeVerbal Learning
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07885085 | Start2027 | PhaseObservational | ConditionsMild cognitive impairment, Substance use and addiction, Delirium, surgery and intensive care, Pain and fatigue | Participants552 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07883148 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants52 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07799584 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07731334 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants384 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07688382 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07672977 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants30 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07667478 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07652775 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Depression and bipolar disorder | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07651085 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Parkinson's disease, Sleep and sleep disorders | Participants65 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07629349 | Start2020 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07611396 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants160 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07608510 | Start2026 | PhaseObservational | ConditionsMild cognitive impairment | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07596940 | Start2023 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants9 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07533084 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Aging, frailty and exercise | Participants265 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07517380 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07512193 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants10 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07402356 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Depression and bipolar disorder | Participants140 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07366346 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07353359 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants65 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07321821 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants60 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07298876 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Aging, frailty and exercise, Sleep and sleep disorders | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07214974 | Start2026 | PhaseEarly phase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Parkinson's disease | Participants600 | Lead sponsorIndustry | StatusNot yet recruiting | Library tests named
|
| NCT07089303 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants750 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07002996 | Start2025 | PhaseNot applicable | ConditionsMild cognitive impairment | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many mild cognitive impairment trials use Verbal Learning?
183 registered mild cognitive impairment studies on ClinicalTrials.gov name it in an outcome measure, 101 of them in a primary outcome: 21% of the condition's 859 studies with a cognitive outcome, against 11% of all of them. It is the 2nd most named test in mild cognitive impairment trials.
Which tests do mild cognitive impairment trials use with Verbal Learning?
The Trail Making Test (84 studies), Verbal Fluency (69 studies) and the Digit Span Test (59 studies).
How many participants do phase 2 mild cognitive impairment trials that use Verbal Learning enroll?
Half of the phase 2 studies that name it enroll 77 participants or fewer, and the middle half enroll 43 to 148. 15 of them give a size.
When do mild cognitive impairment trials measure Verbal Learning?
Half of the primary outcomes that name Verbal Learning are measured within 4 months of the start, and the middle half from 9 weeks to 6 months. 95 primary outcomes give a duration.
How many completed mild cognitive impairment trials that use Verbal Learning have reported results?
46 of the 87 completed studies that name it, 53%, have reported results: 35 posted them on ClinicalTrials.gov, 27 have a results paper linked to the registry record, and 16 did both. The other 41 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Verbal Learning and Grocery Trip Game as one test family, so this page counts their studies together.
Run Verbal Learning in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.